Neuroscience data analytics company IXICO has been chosen as a small-to-medium enterprise (SME) partner in the newly established London Medical Imaging & Artificial Intelligence Centre for Value-Based Healthcare.
Led by King’s College London, the new Centre will develop and train sophisticated artificial intelligence (AI) algorithms from NHS medical images and patient data to provide tools for clinicians to speed up and improve diagnosis and care across a number of patient pathways including dementia, heart failure and cancer.
The Centre has been established as part of the UK Government’s Industrial Strategy Challenge Fund, and brings together a consortium that includes London universities, NHS Trusts, industry partners including global multinationals and UK-based SME’s and the Health Innovation Network.
The Centre will have a focus on transformation and value-based healthcare, and how advanced imaging and AI technologies can be used to improve the patient journey. In addition to government funding, the consortia partners have also made significant investments to leverage UK research strengths and clinical knowledge into becoming a leading industrial player in AI and healthcare.
Giulio Cerroni, chief executive of IXICO, said: "We are excited to be selected to be part of this flagship UK Government initiative to ensure that UK science is at the forefront of the application and impact of artificial intelligence to the future of healthcare. The development and application of artificial intelligence technology will enable IXICO to develop highly valued, innovative solutions to our biopharmaceutical clients in support of their neuroscience clinical development programmes. We are looking forward to collaborations with other leaders across this expanding field of research.”
